Search

Author/Creator Gounder, M.M.

1. Milademetan, an oral MDM2 inhibitor, in well-differentiated/ dedifferentiated liposarcoma: results from a phase 1 study in patients with solid tumors or lymphomas. (October 2020)

Authors:
Gounder, M.M.; Bauer, T.M.; Schwartz, G.K.; LoRusso, P.; Kumar, P.; Kato, K.; Tao, B.; Hong, Y.; Patel, P.; Hong, D.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search